Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts

Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts

Abstract: Measurable residual disease (MRD) is a powerful predictor of clinical outcomes in acute lymphoblastic leukemia (ALL). In addition to its clear prognostic importance, MRD information is increasingly used in clinical decision algorithms to guide therapeutic interventions. Although it is well...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicholas J. Short, Ibrahim Aldoss, Daniel J. DeAngelo, Marina Konopleva, Jessica Leonard, Aaron C. Logan, Jae Park, Bijal Shah, Wendy Stock, Elias Jabbour
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925000503
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items